Lung Cancer Assay - Genrui Biotech Inc.

- English

World’s first chemiluminescence-based seven lung cancer-associated autoantibodies assay.

The LungeKlar®, a convenient blood test for lung nodule risk assessment of lung cancer. (Lung Nodules Risk Assessment)
LungeKlar® Seven Lung Cancer-associated Autoantibodies Detection Kit (CLIA)
The MT120S is a fully automated enzyme-linked chemiluminescence analyzer, dedicated to the Seven Lung Cancer-associated Autoantibodies Detection Kit.
Fully-auto Chemiluminescence Immunoassay Analyzer MT120S

Latest News from Genrui

13
Jul

Jul.13, 2026
Genrui Specific Protein Assays Demonstrate Excellent Performance in the 2026 NCCL External Quality Assessment
17
Feb

Feb.17, 2026
Live From Dubai: Genrui at WhxLabs 2026
25
Nov

Nov.25, 2025
Live From Düsseldorf: Genrui at Medica 2025

Contact Us contact

contact

+86 755 26835560/1/2; +86 755 26678255